Vaccine Access Policy: Navigating Change Under the Current Administration

As the new leadership at the US Department of Health and Human Services continues to evolve its policy agenda, vaccine regulation and access policies remain a dynamic and consequential area for stakeholders across the healthcare ecosystem — particularly payers, pharmaceutical manufacturers and providers. With structural and procedural changes now underway across key public health institutions, the landscape for vaccine evidentiary review, coverage, distribution and administration is shifting rapidly. This timely webinar will unpack the critical developments shaping vaccine access policy in 2025 and explore what these changes mean for the future of vaccine commercialization, payer coverage and provider practices.

Key areas of focus will include:

• Recent changes to the Advisory Committee on Immunization Practices (ACIP), including changes in how evidence is assessed and how coverage recommendations are communicated, and the response to these changes from key medical societies
• Impact of the new COVID-19 regulatory framework on vaccine access and spillover effects for other novel vaccines
• Role of the Make America Healthy Again (MAHA) Commission in re-shaping the immunization schedules and vaccine safety monitoring systems
• Provider adaptation to this changing environment, including responses to federal guidance, evolving payer policies and operational logistics that affect stocking, reimbursement and integration of vaccination into clinical workflows

Given the role these interventions play in disease and illness prevention, staying ahead of vaccine policy is critical for strategic public health decision-making. This webinar will equip pharma, vaccine buyer groups and providers with the insights needed to effectively support patient access and prepare for the downstream effects of shifting immunization policy dynamics.

Register for this webinar to learn how changing vaccine access policy affects commercialization, payer decisions and public health delivery.

Speakers

Sarah Moselle, MPH, Principal, Avalere Health - Moderator

Sarah supports clients with access policy strategy development and implementation in the US and international contexts. She applies her background in public health and global vaccine delivery to create strategic and tactical recommendations for biopharmaceutical clients.

Prior to joining Avalere, Sarah held several research and implementation roles, most recently as a program manager with the global immunization program team at the Sabin Vaccine Institute. She previously worked on a variety of health systems strengthening and preventive health service initiatives with the Aga Khan Foundation in Central Asia and with IQVIA Asia Pacific’s public health team.

Message Presenter

Elif Alyanak, DrPH, Principal, Avalere Health

Elif supports clients with evidence-based research and analysis that spans a variety of healthcare sectors and stakeholders, with a growing focus on evidence-based vaccine policies. With a background in vaccine and immunization research, she applies her skills in strategy, policy, recommendation development and implementation science to a broad range of client projects.

Before joining Avalere, Elif held a variety of positions researching infectious disease prevention and vaccination at the Centers for Disease Control and Prevention (CDC). Formerly an Oak Ridge Institute for Science and Education (ORISE) Fellow and Senior Analyst/Epidemiologist within the National Center for Immunization and Respiratory Diseases (NCIRD), she supported many federal government vaccination studies and policy research. Additionally, Elif managed systematic reviews and meta-analyses and synthesized clinical vaccine literature while directly supporting the Advisory Committee on Immunization Practices (ACIP).

Message Presenter

Mitchell Finkel, Associate Principal, Avalere Health

Mitchell supports clients in preventive services on United States federal and state policy.

Mitchell has expertise in government-regulated market policy and access (e.g., Medicare, Medicaid and Federally Qualified Health Centers) coverage and reimbursement policies for preventive products. Mitchell assists clients in understanding the implications of the Advisory Committee on Immunization Practices, the United States Preventive Services Task Force and Health Resource Service Administration Recommendations. Before joining Avalere, Mitchell interned at Todd Strategy, where he researched and summarized regulatory and legislative issues affecting the pharmaceutical and biotech sectors.

Message Presenter